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The addition of a single N-acetylglucosamine residue O-linked to serine and threonine
residues of nuclear and cytoplasmic proteins is a widespread modification throughout all
eukaryotes. The conventional method for detecting and locating sites of modification is a
multi-step radioactivity-based protocol. In this paper we show that using quadrupole
time-of-flight (Q-TOF) mass spectrometry, modification sites can be identified at a significantly
higher sensitivity than previous approaches. This is the first demonstration that sites of
O-GlcNAcylation can be identified directly using mass spectrometry. (J Am Soc Mass
Spectrom 2001, 12, 1106–1113) © 2001 American Society for Mass Spectrometry
Since its first discovery 17 years ago [1], a largevariety of nuclear and cytoplasmic proteins havebeen shown to be post-translationally modified by
the addition of single N-acetylglucosamine (GlcNAc)
moieties to serine and threonine residues [2, 3]. This
modification has been found to be transient, and is
believed to regulate protein function. Enzymes which
catalyse the addition [4, 5] and removal [6, 7] of GlcNAc
have been identified. Proteins bearing this modification
are also phosphoproteins and are generally involved in
multimeric complexes. This has lead to suggestions that
this modification plays an antagonistic role to phos-
phorylation, and may be involved in protein-protein
interactions [8–11]. It has also been implicated in pro-
tein stability [12]. The most common method for detect-
ing this modification is to perform an in vivo addition
of [3H]galactose to the GlcNAc residue using a galacto-
syltransferase [1]. Labeled proteins can then be visual-
ized by autoradiography on a polyacrylamide gel. To
determine sites of modification the protein is radiola-
beled, enzymatically digested and peptides are sepa-
rated by high-performance liquid chromatography
(HPLC). Fractions are monitored for radioactivity, then
“hot’ fractions are analysed by Edman sequencing. By
monitoring the radioactivity after each cycle of Edman
degradation, the modified residue can be identified
[13]. However, Edman sequencing cannot readily cope
with mixtures of peptides. Therefore, multiple steps of
purification are often required before a peptide is
purified to homogeneity. Thus, large amounts of mod-
ified protein were required in order to identify sites.
Mass spectrometry is significantly more sensitive
than Edman peptide sequence analysis, and so should
be able to detect GlcNAcylation sites from lower levels
of protein. However, the glycosidic bond linking the
GlcNAc and the amino acid is significantly more labile
than the bonds in the peptide backbone. Hence, when
such a glycopeptide is vibronically activated in order to
carry out sequence analysis by mass spectrometry, the
sugar residue is generally eliminated before the peptide
backbone bonds dissociate, giving rise to deglycosy-
lated fragment ions. Fragment ions retaining glycosyl-
ation are usually of low intensity and can be hidden
below the chemical noise in the spectrum.
A base catalyzed b elimination reaction may be
utilized to convert glycosylserine and glycosylthreonine
residues into dehydroalanine and dehydrobutyric acid
residues. MS-MS has been employed to locate these
modified residues on synthetic peptides [14, 15], but has
yet to be used to identify modified residues from a
GlcNAcylated protein.
The new generation of quadrupole time of flight
mass spectrometers provide collision-induced dissocia-
tion (CID) spectra with significantly lower chemical
noise than spectra acquired by triple quadrupole or
matrix-assisted laser desorption ionization (MALDI)-
PSD instruments. This situation increases the practical
dynamic range available which can be exploited to
detect low intensity fragment ions. Indeed, it has re-
cently been shown that glycosylation sites from mucin-
type (O-GalNAc linked) and O-fucose linked glycopep-
tides can be identified using such instrumentation [16,
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17]. In this paper, we describe the identification of sites
of modification of GlcNAcylated peptides and a-crys-
tallin using an ESI-Q-TOF mass spectrometer.
Experimental
Materials
HPLC grade water and acetonitrile were purchased
from Rathburn (Walkerburn, Scotland), formic acid and
trifluoroacetic acid (TFA) from Romil (Cambridge, UK).
The HPLC columns were obtained from LC Packings
(Amsterdam, Netherlands).
Alpha crystallin was purchased from Sigma (Poole,
UK). Synthetic GlcNAcylated peptides were a gift from
Professor Gerry Hart, John Hopkins School of Medicine,
Baltimore.
Galactosylation of Peptides
Synthetic peptides were galactosylated using a protocol
adapted from a published procedure [18]. The labeling
buffer contained 3.75 ml 25 mM ammonium bicarbon-
ate, 0.25 ml galactose buffer (0.1 mM galactose, 0.1 mM
Hepes-NaOH, 0.15 mM NaCl, 50 mM MgCl2), 1 ml
autogalactosylated galactosyltransferase (1 mU) and
0.5 ml 160 mM UDP-galactose in 25 mM ammonium
bicarbonate containing 0.5 mM 59-AMP. Labeling was
carried out at 37 °C for 6 h to try and ensure saturation
labeling.
Nanoelectrospray MS
Samples were sprayed from Protana tips (Odense,
Denmark).
Solution Digest
Two hundred nanograms of a-crystallin was digested
with six nanograms of modified trypsin in 25 mM
ammonium bicarbonate and incubated at 37 °C for 2 h.
1D SDS PAGE
Four hundred nanograms of a-crystallin was loaded
onto a 12% polyacrylamide mini-gel (8 cm 3 10 cm 3
0.5 mm) and run on a Hoeffer mini-gel system (Amer-
sham-Pharmacia, Amersham, UK). The gel was then
stained with Coomassie Brilliant Blue for 1 h and
destained for 3 h, before bands were excised.
In-Gel Digestion Protocol
Excised bands were further destained in 25 mM ammo-
nium bicarbonate/50% acetonitrile, vacuum centri-
fuged to dryness, then allowed to swell in 5 ml 25 mM
ammonium bicarbonate containing 4 ng/ml modified
trypsin for 5 min. Gel pieces were then overlayed with
a further 25 ml 25 mM ammonium bicarbonate and
digested overnight at 37 °C.
Peptides were extracted with two changes of 20 ml
50% acetonitrile/5% TFA, vacuum centrifuged to dry-
ness and resuspended in 10 ml water prior to analysis.
On-Line Electrospray Mass Spectrometry
HPLC was carried out using an Ultimate HPLC with
connected Famos Autosampler (LC Packings, Amster-
dam, Netherlands). Samples were loaded onto a guard
column (300 mm ID 3 5 cm C18 PepMap) in the
injection loop, and washed with 0.1% formic acid at
40 ml/min for 2 min using a Switchos pump (LC
Packings). Peptides were then separated on an analyti-
cal column (75 mm ID 3 15 cm C18 PepMap) at a flow
rate of 200 nl/min with a gradient from 5% to 40%
buffer B (80% acetonitrile/0.1% formic acid) over a
period of 32 min.
Nano-electrospray was performed on a Q-TOF (Mi-
cromass, Manchester, UK) using a New Objective
(Cambridge, MA) spraying assembly, with distal coated
tips (75 mM i.d. pulled to 15 mM at the tip). Automatic
function switching between survey MS and MS-MS
modes was used. Using this method, when a multiply-
charged peak above 4 counts/s was detected in the
mass spectrum it was automatically selected for tandem
MS analysis. Up to two precursor ions could be selected
for MS-MS at any time. In the initial analysis of the
sample, four MS-MS spectra at two different collision
energies were acquired on each selected parent ion,
then it switched back to MS mode to look for other ions.
For ions of m/z 400–900, collision energies of 28 V and
32 V were used, whereas for peptides of m/z 900–2000,
collision energies of 30 V and 35 V were used. Once
GlcNAc modified peptides were located, a second run
was carried out, performing MS-MS only on modified
peptides. This time MS-MS was performed for as long
as the peak stayed above 4 counts/s (typically 40–50 s).
Results and Discussion
Identifying Sites of Modification of O-GlcNAc
Containing Synthetic Peptides
Because of the high lability of the glycosidic bond
between GlcNAc and peptide side chain residues, some
of the GlcNAc residue can be cleaved at normal cone
voltages, forming a characteristic oxonium ion at m/z
204.1 Da. This mass value can be used to detect and
locate all types of glycosylated peptides containing
N-acetylhexosamine(s), all N-linked and those O-linked
with either GalNAc or GlcNAc-type [14, 19, 20]. How-
ever, for the purposes of subsequent identification of
the site of glycosylation in-source loss of the GlcNAc
residue must be minimized. Figure 1 shows spectra of a
synthetic glycopeptide YSPTSPSK at two different cone
voltages. At a cone voltage of 35 V, the base peak in the
spectrum is the deglycosylated component [M 1 H]1
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m/z 866.42, whereas at a lower cone voltage of 25 V this
deglycosylated peak is no longer present, and as a
result the glycosylated peptide ion [M 1 2H]21 m/z
535.27 is of significantly higher intensity.
The CID spectra for the glycosylated peptide [M 1
2H]21 m/z 535.27 at two different collision energies are
shown in Figure 2. The most intense peaks in each
spectrum correspond to the parent ion minus the
GlcNAc (m/z 866.42) and the GlcNAc oxonium ion (m/z
204.09). This peptide is representative of a typical
tryptic peptide, bearing a basic C-terminal residue.
Hence, the resulting CID spectrum contains almost
exclusively y sequence ions [21]. The peaks at m/z 819.41
and m/z 616.33 correspond to glycosylated and degly-
cosylated analogs of the y6 fragment respectively. As
can be seen, the intensity of the glycosylated ion is
similar at the two collision energies, whereas the deg-
lycosylated ion is much less intense at the lower colli-
sion energy, such that the glycosylated fragment ion is
now relatively more intense. Thus, under these condi-
tions, if a non-glycosylated fragment ion is observed, if
a glycosylated version does exist, this should also be
present in the spectrum. The y4 fragment occurs as
glycosylated (m/z 621.28) and deglycosylated (m/z
418.24) ions. The spectrum contains a y3 ion at m/z
331.20, but there is no corresponding glycosylated ver-
sion at m/z 534.28. This result assigns the GlcNAc
modification to the serine at residue 5 or 7, with the lack
of glycosylated y3 making serine 5 more probable.
When another synthetic peptide PGGSTPVS
SANMM was subjected to nanoelectrospray CID at a
low collision energy, the spectrum was dominated by
peaks corresponding to the oxonium ion of the cleaved
GlcNAc residue at m/z 204.12, and the singly charged
parent ion minus the GlcNAc (m/z 1235.72) (Figure 3).
The doubly charged parent ion (m/z 719.97) and the
doubly charged parent ion minus GlcNAc (m/z 618.41)
are also quite large. However, at this low collision
energy, the glycosylated fragment ions y6 1 GlcNAc
(m/z 843.52) and b8 1 GlcNAc (m/z 886.61) are present
and clearly establish the site of modification as serine 8.
Identifying Sites of Modification of O-GlcNAc-Gal
Labeled Synthetic Peptides
Since it is common practice to derivatize the GlcNAc
residue enzymatically with radiolabeled galactose for
purposes of locating glycosylated proteins and for iso-
lating modified peptides from a complex mixture using
the lectin Ricinus communis (RCA1) [20, 22], we investi-
gated what effect the additional galactose residue might
have on the ability to identify the modified residue by
tandem MS. To this end, we galactosylated our syn-
thetic peptides, and recorded their CID spectra. An
example is shown in Figure 4. As previously reported,
diagnostic fragment ions from the GlcNAc-Gal disac-
charide moiety (m/z 366.23) and GlcNAc monosaccha-
ride residue (m/z 204.13) are observed [14, 20]. As a
result, the fragment ion spectrum contains three frag-
ment ions for each peptide cleavage; a GlcNAc-Gal
modified peptide, a GlcNAc modified peptide, and a
fully deglycosylated peptide. For the y6 fragment this
trio appears at m/z 1005.58, m/z 843.45, and m/z 640.39
respectively, and for the b8 ion they are at m/z 1048.68,
m/z 886.61, and m/z 683.50. These results suggest that
the attachment of the additional galactose does not have
a significant effect on the stability of the GlcNAc-
peptide glycosidic link. Thus, it does not affect the
ability to identify glycosylation sites. However, it does
cause the formation of additional glycosylated fragment
ions that can provide confirmation of the assignment of
glycosylated peaks.
Sensitivity of Detection
The sensitivity for detection of GlcNAc modified pep-
tides is clearly much lower than the level required for
identification of the site of modification. To determine
the lowest level at which a site can be identified,
decreasing amounts of GlcNAc modified synthetic pep-
tide were analyzed by LC-MS-MS. Figure 5 shows the
region of the MS-MS spectrum of PGGSTPVSSANMM
containing the b8 1 GlcNAc and y6 1 GlcNAc at the
level of 100 fmole and 50 fmole loaded on column. At
Figure 1. MS Spectra of synthetic GlcNAc modified peptide
YSPTSGPSK at cone voltages of 35 V (a) and 25 V (b). Peak at m/z
535.27 corresponds to the doubly charged glycosylated parent ion,
whereas the peak at m/z 866.42 is the singly charged deglycosy-
lated parent ion. GlcNAc modified fragment ions are indicated
with aG. The peak at m/z 437.21 is a contaminant.
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Figure 2. CID Spectra of GlcNAcylated YSPTSGPSK at two different collision energies. In the whole
spectrum (a) main peaks include the doubly charged parent ion (m/z 535.27), deglycosylated parent
ion (m/z 866.42), GlcNAc oxonium ion (m/z 204.09), y6 1 GlcNAc (m/z 819.41) and deglycosylated y6
(m/z 616.33). (b) Zoom in on region containing, among other ions, the glycosylated y4 at m/z 621.34,
which is sufficient to determine that serine 5 is GlcNAc modified.
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both levels the y6 1 GlcNAc (m/z 843.15) is present with
a good signal to noise ratio. At the 100 fmole level the b8
1 GlcNAc (m/z 886.18) is clearly present, but at the 50
fmole level the peak is present at a signal to noise of less
than 2:1. These results suggest that the limit for locating
sites of modification of this peptide by LC-MS-MS is in
the range of 100 fmoles.
The limit for identifying a GlcNAc modification site
by nanoelectrospray MS was also investigated. From a
solution at 100 fmoles/ml, after 5 min spraying the site
could be identified (Figure 6). At a flow rate of 10 nl/min
this would correspond to a consumption of about 5 fmoles
of modified peptide.
Identifying Sites of O-GlcNAcylation of
a-Crystallin
For this technique to be useful it must be able to identify
sites of modification from proteins. a-crystallin A chain
has been shown to be GlcNAc modified on serine 162
[23], and a-crystallin B chain to be modified on threo-
nine 170 [24]. It has been reported that a GlcNAc-Gal
modified tryptic peptide from the A chain can be
detected by LC-MS. MS-MS on this peptide was per-
formed as well [20]. However, the site of modification
could not be established from the CID spectrum re-
ported.
Two hundred nanograms of a-crystallin was di-
gested in solution with trypsin. Twenty percent of the
digest was then analysed by LC-MS with automatic
switching to MS-MS when a peak was detected. From
this, 11 different peptides were matched to a-crystallin
A chain and another 11 different peptides matched to
the a-crystallin B chain. The A and B chains of a-crys-
tallin are present at similar levels. Therefore, it is
estimated that there were 100 ng of each a chain
digested.
By screening through the MS survey spectrum, a
peak for the glycosylated peptide corresponding to
residues 158–173 (the C-terminus of the protein) of a
crystallin was observed at [M 1 3H]31 m/z 615.62
(Figure 6). Unfortunately this peak was not selected
automatically for MS-MS because there were too many
other co-eluting peaks, including the non-glycosylated
version of this peptide [M 1 3H]31 m/z 547.93, [M 1
2H]21 m/z 821.39. These two peaks were selected for
MS-MS, and gave comprehensive spectra to confirm the
identity of this peptide (data not shown). As can be seen
from Figure 7, the intensity of the peak for the glyco-
Figure 3. CID spectrum of glycosylated PGGSTPVSGSANMM.
Peaks in whole spectrum (a) include doubly charged parent ion
(m/z 719.97), deglycosylated parent ion (MH1 m/z 1235.72, MH2
21
m/z 618.41), and GlcNAc oxonium ion (m/z 204.13). (b) Magnified
region containing the glycosylated y6 (m/z 843.52) and b8 ions (m/z
886.61), which identify serine 8 as being modified.
Figure 4. CID Spectrum of GlcNAc-Gal modified PGGSTPV
(SGGal)SANMM. Whole Spectrum (a) contains parent ion (m/z
801.00), completely deglycosylated parent (m/z 1235.76), GlcNAc
(m/z 204.13) and GlcNAc-Gal oxonium ions (m/z 366.23). (b)
Magnified region containing unmodified, GlcNAc modified, and
GlcNAc-Gal modified fragment ions of y6 and b8.
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sylated version of the peptide is around 5% that of the
unmodified version. It is known that a GlcNAc modi-
fied peptide gives a disproportionately low signal by
electrospray in comparison with the corresponding
unmodified peptide [25], but even so, this suggests that
at most 10% of the protein was glycosylated at this site.
A peptide containing the proposed GlcNAcylation site
in a–crystallin B chain (residues 158–175) was observed
in a non-glycosylated state ([M 1 4H]41 m/z 488.29, [M
1 3H]31 m/z 650.68). However, there was no sign of a
corresponding glycosylated version. Fifty percent of the
sample was then loaded for a further LC-MS run.
However, this time it was specified within the software
to only perform MS-MS when the triply charged glyco-
sylated peptide species was detected. As the MS-MS
spectra of the unmodified peptide in the initial run
showed comprehensive fragmentation and no parent
ion remaining at a collision energy of 28 V, collision
energies of 22 V and 25 V were used on the glycosylated
peptide. The MS-MS spectrum is shown in Figure 7. The
dominant peaks in this spectrum are the doubly
charged deglycosylated y14 ion at m/z 729.35, the
GlcNAc oxonium ion (m/z 204.08), and several other
low mass ions corresponding to fragments of the
GlcNAc or the internal fragment PS. The spectrum as a
whole contains an unusually large number of internal
fragment ions. This is due to the presence of three
proline residues in the sequence, since cleavages on the
N-terminal side of proline residues are highly favored
Figure 6. Survey MS spectrum containing peaks corresponding
to unmodified and GlcNAc modified tryptic peptides of residues
158–173 of aA Crystallin.
Figure 5. Region of LC-MS-MS spectra of 100 fmoles (a) and 50
fmoles (b) of glycosylated PGGSTPVSSANMM. The same region
is shown in (c) from 5 min nanoelectrospray acquisition at a
concentration of 100 fmoles/ul. The GlcNAc modified y6 (m/z
843.38) and b8 (m/z 886.29) ions are sufficient to locate the site of
glycosylation.
Figure 7. MS-MS of GlcNAc modified peptide 158–173 from
solution and in-gel digests of Alpha A Crystallin. The whole
MS-MS spectrum from the solution digest is shown in (a), and a
magnified region containing GlcNAcylated fragment ions from
solution (b) and in-gel digests (c) that determine Serine 5 (Serine
162 from aA Crystallin) as the site of GlcNAc modification.
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by CID [26]. There are a number of glycosylated frag-
ment ions in the spectrum. However, the most impor-
tant ions in this spectrum for determining the site of
modification are at m/z 1029.50 and a weaker ion at m/z
901.39. These correspond to glycosylated internal ions
PVSREEK and PVSREE respectively. As there is only
one possible residue in these fragments which can bear
the glycosylation, serine 162 is unequivocally confirmed
as the site of modification.
This spectrum has been obtained from fifty percent
of a digest of one hundred nanograms of aA crystallin,
which would correspond to 2.5 pmoles of protein digest
loaded onto the HPLC. However, as less than 10% of
the protein is modified, this spectrum must represent, at
most, 250 fmoles.
The same site could also be identified from an in gel
digest of the a-crystallin A chain. When four hundred
nanograms of a-crystallin was loaded onto 12% poly-
acrylamide gel, two bands of equal intensity were
visualized by Coomassie staining. From fifty percent of
the lower band (A chain) the site of modification was
confirmed (Figure 7c).
Conclusions
In this investigation we have shown the feasibility of
using the new generation of quadrupole orthogonal
acceleration time-of-flight mass spectrometers for the
identification of sites of O-GlcNAcylation. The identifi-
cation of GlcNAcylation sites has been challenging for a
number of reasons. The peptide-sugar glycosidic link is
extremely labile (dramatically more so than analogous
peptide™phosphate bonds), and it is cleaved to leave an
unmodified serine/threonine, leaving no residual indi-
cation that the residue was modified. There is no
consensus sequence for sites of modification [2]; how-
ever, sites of modification are usually surrounded by
other serines and threonine residues. Therefore, com-
prehensive CID spectra are necessary in order to iden-
tify which residue is modified.
Previously, mass spectrometry has only been able to
identify the sites of modification of synthetic peptides
after performing a base catalysed b-elimination of the
sugar residue [14, 15]. This procedure converts glyco-
sylserine and glycosylthreonine to a dehydroalanine
and a 2-aminobutyric acid respectively, and these mod-
ified amino acid residues can be located using CID MS.
In this paper we have shown that it is now possible to
identify sites of O-GlcNAc modification without the
need to expose such glycopeptides to harsh basic con-
ditions. The elimination of this step should provide an
increase in overall sensitivity for such analyses.
The fact that the GlcNAc can be readily released by
in source fragmentation even at modest cone voltages to
form the diagnostic 204.1 oxonium ion has been shown
to be useful for locating glycosylated peptides. How-
ever, for subsequent location of the site of glycosylation
it is necessary to minimize this cleavage pathway.
Hence, we have shown that for analyzing GlcNAc
modified peptides it is critical to use reduced cone
voltages.
In the CID spectra of GlcNAc modified peptides, the
glycosylated fragment ions are generally of very low
intensity. The optimal collision energy for observation
of glycosylated fragment ions is lower than the optimal
collision energy for fragmenting the peptide for de
novo sequencing, such that there is often still a signifi-
cant amount of parent ion present in the CID spectrum.
At this optimal collision energy the glycosylated frag-
ment ions can actually be of higher intensity than the
deglycosylated fragment ions, although both are of low
intensity, and would be difficult to observe without the
low chemical noise of tandem MS spectra acquired on
Q-TOF mass spectrometers.
Tryptic peptides with their C-terminal derived se-
quence ions in CID spectra are very attractive for
sequencing peptides [27]. However, for the purpose of
identifying a site of modification, overlapping b and y
ions are generally required, otherwise the lack of gly-
cosylated fragment ion must be used as an indirect
indication. Therefore, trypsin may not always be the
enzyme of choice for identifying O-GlcNAc modifica-
tion sites. Indeed, the aA crystallin peptide in this paper
is the C-terminal peptide of the protein, and is devoid of
a basic C-terminal residue. Also, the location of two
proline residues on either side of the modification site
triggered formation of convenient internal fragment
ions to determine the site of modification. Nearby
proline residues are fairly common for GlcNAc sites
identified [2], so this internal fragmentation pattern
may be observed for other GlcNAcylated peptides.
At a low collision energy the glycosylated fragment
ions can be more intense than the deglycosylated peaks,
but for larger peptides that require more collision
energy to undergo unimolecular dissociation, observa-
tion of glycosylated fragments may be thwarted. There-
fore, it is desirable to work with short modified pep-
tides (less than 15 residues). This should be a guiding
factor in choice of enzymes, and in some cases digestion
with more than one enzyme may be desirable. A major
problem with characterizing O-GlcNAcylation is that
the stoichiometry of modification is often extremely
low. In many cases precursor ion scanning to locate
modified peptides will be required [20].
The detection level to identify GlcNAc modified
peptides is much lower than the amount required to
locate sites of modification. The most sensitive methods
used at present for identifying sites have a limit of
detection at the low picomole level [15]. In this paper
we have shown that by using quadrupole-TOF MS-MS,
the limit of detection has been reduced by an order of
magnitude to the mid-femtomole level. At this level we
have shown that GlcNAcylation sites may be identified
from a protein after either solution or in gel digestion.
These results should facilitate studies of new GlcNAcy-
lation sites without prior over-expression of a protein.
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